All tenders
75N93020C00017
TO IDENTIFY AND DEVELOP A NON-BETA-LACTAM PBP INHIBITOR (NBP) WITH BROAD SPECTRUM OF ACTIVITY AGAINST MDR GRAM-NEGATIVE ESKAPE PATHOGENS.
National Institutes of Health · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedOtherFederal
Basic information
- Reference number
- 75N93020C00017
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- TO IDENTIFY AND DEVELOP A NON-BETA-LACTAM PBP INHIBITOR (NBP) WITH BROAD SPECTRUM OF ACTIVITY AGAINST MDR GRAM-NEGATIVE ESKAPE PATHOGENS.
- Source
- USASpending (Federal)
- Source ID
- usa-75N93020C00017
Details
- Location
- United States
Description
TO IDENTIFY AND DEVELOP A NON-BETA-LACTAM PBP INHIBITOR (NBP) WITH BROAD SPECTRUM OF ACTIVITY AGAINST MDR GRAM-NEGATIVE ESKAPE PATHOGENS. Awarded to: ENTASIS THERAPEUTICS, INC. Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2020/07/01 12:00:00 AM UTC
- Closing date
- 2022/12/31 12:00:00 AM UTC
Estimated value
$5.6M USD
Classification
Normalized category
Other